Protect Patients from Costly Care Act
Summary
The "Protect Patients from Costly Care Act" aims to repeal specific changes made by Public Law 119-21 regarding Medicaid cost-sharing requirements and the exclusion of orphan drugs from the Medicare Drug Price Negotiation Program. This bill seeks to revert to the previous regulations concerning these aspects of healthcare. The bill specifically targets Section 71120 and 71203 of the previous act.
Expected Effects
If enacted, the bill would eliminate the changes to Medicaid cost-sharing and reinstate the inclusion of orphan drugs in the Medicare Drug Price Negotiation Program. This would likely affect both patients and pharmaceutical companies. The rescission of appropriated amounts under section 71120(c) would also impact funding allocations.
Potential Benefits
- Potentially lowers healthcare costs for Medicaid recipients by repealing increased cost-sharing requirements.
- May improve access to orphan drugs by including them in price negotiations.
- Could lead to more affordable medications for individuals with rare diseases.
- Aims to restore the previous framework of Medicaid and Medicare drug pricing.
- May provide financial relief to vulnerable populations relying on these programs.
Most Benefited Areas:
Potential Disadvantages
- Pharmaceutical companies may experience reduced revenue due to the inclusion of orphan drugs in price negotiations.
- Rescinding appropriated amounts could impact specific healthcare initiatives previously funded.
- Potential for increased government spending on Medicaid due to the rollback of cost-sharing measures.
- The bill may face opposition from groups that supported the original changes in Public Law 119-21.
- Uncertainty regarding the long-term financial implications of repealing these changes.
Most Disadvantaged Areas:
Constitutional Alignment
The bill appears to align with the general welfare clause of the Constitution, as it aims to protect patients from costly care. Article I, Section 8 grants Congress the power to collect taxes and provide for the general welfare of the United States. The specific provisions of the bill relate to healthcare policy, which falls under the purview of Congress's legislative powers.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).